These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17713155)

  • 1. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene.
    Andrei G; Snoeck R; De Clercq E; Esnouf R; Fiten P; Opdenakker G
    J Gen Virol; 2000 Mar; 81(Pt 3):639-48. PubMed ID: 10675401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
    Andrei G; Gillemot S; Topalis D; Snoeck R
    J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines.
    De Clercq E; Andrei G; Balzarini J; Leyssen P; Naesens L; Neyts J; Pannecouque C; Snoeck R; Ying C; Hocková D; Holý A
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):331-41. PubMed ID: 16247948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
    Bestman-Smith J; Boivin G
    J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
    Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus resistance to antiviral drugs.
    Morfin F; Thouvenot D
    J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
    Sauerbrei A; Deinhardt S; Zell R; Wutzler P
    Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
    Sergerie Y; Boivin G
    Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    Snoeck R; Andrei G; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice.
    Pelosi E; Rozenberg F; Coen DM; Tyler KL
    Virology; 1998 Dec; 252(2):364-72. PubMed ID: 9878615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
    Stránská R; van Loon AM; Bredius RG; Polman M; Nienhuis E; Beersma MF; Lankester AC; Schuurman R
    Antivir Ther; 2004 Feb; 9(1):97-104. PubMed ID: 15040541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
    Hwang YT; Smith JF; Gao L; Hwang CB
    Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.